Evotec SE (EVO) Shares Outstanding (2009 - 2026)
Evotec SE's (EVO) quarterly Shares Outstanding (Entity) came in at $355.6 million in Q4 2025, little changed year-over-year from $355.1 million in Q4 2024, and little changed quarter-over-quarter from $355.1 million in Q4 2024.
Analysis
Evotec SE (EVO) Shares Outstanding (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Shares Outstanding (Entity) across 8 years of filings, most recently posting $355.6 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) changed 0.13% year-over-year to $355.6 million; the TTM figure through Dec 2025 stood at $355.6 million (changed 0.13% YoY), while the FY2025 annual figure was $355.6 million, changed 0.13% from the prior year.
- Shares Outstanding (Entity) came in at $355.6 million for Q4 2025 at Evotec SE, roughly flat from $355.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $355.6 million in Q4 2025 to a low of $353.2 million in Q4 2021.
- Average Shares Outstanding (Entity) over 5 years is $354.4 million, with a median of $354.4 million recorded in 2023.
- Year-over-year, Shares Outstanding (Entity) advanced 7.74% in 2021 and gained 0.13% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $353.2 million in 2021, then climbed by 0.2% to $353.9 million in 2022, then grew by 0.13% to $354.4 million in 2023, then advanced by 0.21% to $355.1 million in 2024, then rose by 0.13% to $355.6 million in 2025.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $355.6 million in Q4 2025, $355.1 million in Q4 2024, and $354.4 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.57 Bn | 40.49 Bn | 1.44 Bn | 166.10 Mn |
| 2 | Medpace Holdings | 16.45 Bn | 15.94 Bn | 201.64 Mn | 28.17 Mn |
| 3 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 48.02 Mn |
| 4 | Icon | 12.56 Bn | 11.63 Bn | 479.29 Mn | 78.42 Mn |
| 5 | Fortrea Holdings | 1.59 Bn | 1.42 Bn | 139.20 Mn | 94.80 Mn |
| 6 | Evotec SE | 625.08 Mn | 199.20 Mn | - | 355.16 Mn |
| 7 | Ginkgo Bioworks Holdings | 420.38 Mn | 335.84 Mn | 18.44 Mn | 62.09 Mn |
| 8 | Champions Oncology | 70.27 Mn | 70.27 Mn | 7.03 Mn | 13.83 Mn |
| 9 | MindWalk Holdings | 59.92 Mn | 51.64 Mn | 1.82 Mn | 46.38 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 5.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 355.16 Mn |
| Mar 31, 2026 | 355.16 Mn |
| Dec 31, 2025 | 355.16 Mn |
| Sep 30, 2025 | 354.59 Mn |
| Jun 30, 2025 | 354.59 Mn |
| Mar 31, 2025 | 354.59 Mn |
| Dec 31, 2024 | 354.59 Mn |
| Sep 30, 2024 | 353.83 Mn |
| Jun 30, 2024 | 353.83 Mn |
| Mar 31, 2024 | 353.83 Mn |
| Dec 31, 2023 | 353.83 Mn |
| Aug 29, 2023 | 353.35 Mn |
| Jun 30, 2023 | 353.35 Mn |
| Mar 31, 2023 | 353.35 Mn |
| Dec 31, 2022 | 353.35 Mn |
| Sep 30, 2022 | 332.81 Mn |
| Jun 30, 2022 | 332.81 Mn |
| Mar 31, 2022 | 332.81 Mn |
| Dec 31, 2021 | 332.81 Mn |
| Sep 30, 2021 | 307.50 Mn |